Additionally, in the mouse model where NFκB signaling was disrupted, a reduction in mammary tumor formation was observed, indicating NFκB signaling as a requirement for tumorigenesis for HER2+ tumors [60]. The gene discussed is NFKB1; the disease is breast cancer.